On November 18th and 19th present and new industry and academic partners came together for the annual PROXIDRUGS retreat to discuss latest developments and challenges in research on targeted protein degradation, degraders and molecular glues, including upcoming plans for the 2nd phase of PROXIDRUGS starting in January 2025. Project talks covered the whole spectrum of early proxidrug and technology development, highlighting the possibilities in this field with so much potential for discovery and innovation!
Everyone meeting face-to-face at our retreats maximizes the benefit of the cluster’s ecosystem, offering the opportunity to ask all the burning questions that can help to better understand different perspectives and expand knowledge in the various areas of expertise needed to develop these novel therapeutics. This year it was an additional pleasure to have 13 new partners on board.